Literature DB >> 20959457

HLA-DP, HLA-DQ, and HLA-DR have different requirements for invariant chain and HLA-DM.

Marcel van Lith1, Rosanna M McEwen-Smith, Adam M Benham.   

Abstract

The MHC is central to the adaptive immune response. The human MHC class II is encoded by three different isotypes, HLA-DR, -DQ, and -DP, each being highly polymorphic. In contrast to HLA-DR, the intracellular assembly and trafficking of HLA-DP molecules have not been studied extensively. However, different HLA-DP variants can be either protective or risk factors for infectious diseases (e.g. hepatitis B), immune dysfunction (e.g. berylliosis), and autoimmunity (e.g. myasthenia gravis). Here, we establish a system to analyze the chaperone requirements for HLA-DP and to compare the assembly and trafficking of HLA-DP, -DQ, and -DR directly. Unlike HLA-DR1, HLA-DQ5 and HLA-DP4 can form SDS-stable dimers supported by invariant chain (Ii) in the absence of HLA-DM. Uniquely, HLA-DP also forms dimers in the presence of HLA-DM alone. In model antigen-presenting cells, SDS-stable HLA-DP complexes are resistant to treatments that prevent formation of SDS-stable HLA-DR complexes. The unexpected properties of HLA-DP molecules may help explain why they bind to a more restricted range of peptides than other human MHC class II proteins and frequently present viral peptides.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20959457      PMCID: PMC3003381          DOI: 10.1074/jbc.M110.148155

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Intracellular transport of class II MHC molecules directed by invariant chain.

Authors:  V Lotteau; L Teyton; A Peleraux; T Nilsson; L Karlsson; S L Schmid; V Quaranta; P A Peterson
Journal:  Nature       Date:  1990-12-13       Impact factor: 49.962

2.  Identification of a rabies virus T cell epitope on the basis of its similarity with a hepatitis B surface antigen peptide presented to T cells by the same MHC molecule (HLA-DPw4).

Authors:  E Celis; J Larson; L Otvos; W H Wunner
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

3.  MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding.

Authors:  R N Germain; L R Hendrix
Journal:  Nature       Date:  1991-09-12       Impact factor: 49.962

4.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.

Authors:  J H Brown; T S Jardetzky; J C Gorga; L J Stern; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1993-07-01       Impact factor: 49.962

5.  Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules.

Authors:  K Falk; O Rötzschke; S Stevanović; G Jung; H G Rammensee
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

6.  Transport properties of free and MHC class II-associated oligomers containing different isoforms of human invariant chain.

Authors:  B Arunachalam; C A Lamb; P Cresswell
Journal:  Int Immunol       Date:  1994-03       Impact factor: 4.823

7.  HLA-DPB1 glutamate 69: a genetic marker of beryllium disease.

Authors:  L Richeldi; R Sorrentino; C Saltini
Journal:  Science       Date:  1993-10-08       Impact factor: 47.728

8.  The generation of immunogenic peptides can be selectively increased or decreased by proteolytic enzyme inhibitors.

Authors:  L Vidard; K L Rock; B Benacerraf
Journal:  J Immunol       Date:  1991-09-15       Impact factor: 5.422

9.  The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules.

Authors:  E A Elliott; J R Drake; S Amigorena; J Elsemore; P Webster; I Mellman; R A Flavell
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

10.  Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistance alpha beta heterodimers in endosomes.

Authors:  J J Neefjes; H L Ploegh
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598

View more
  24 in total

Review 1.  MHC class II antigen presentation by dendritic cells regulated through endosomal sorting.

Authors:  Toine ten Broeke; Richard Wubbolts; Willem Stoorvogel
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-12-01       Impact factor: 10.005

2.  Distinct editing functions of natural HLA-DM allotypes impact antigen presentation and CD4+ T cell activation.

Authors:  Miguel Álvaro-Benito; Eliot Morrison; Friederike Ebner; Esam T Abualrous; Marie Urbicht; Marek Wieczorek; Christian Freund
Journal:  Cell Mol Immunol       Date:  2018-11-22       Impact factor: 11.530

Review 3.  HLA-DM: arbiter conformationis.

Authors:  Andrea Ferrante
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

4.  Isolation and characterization of new human carrier peptides from two important vaccine immunogens.

Authors:  Paeton L Wantuch; Lina Sun; Rachel K LoPilato; Jarrod J Mousa; Robert S Haltiwanger; Fikri Y Avci
Journal:  Vaccine       Date:  2020-01-28       Impact factor: 3.641

Review 5.  Pathways of antigen processing.

Authors:  Janice S Blum; Pamela A Wearsch; Peter Cresswell
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

6.  The HLA-B*4601-DRB1*0901 haplotype is positively correlated with juvenile ocular myasthenia gravis in a southern Chinese Han population.

Authors:  Hui-Yu Feng; Li-Xuan Yang; Wei-Bin Liu; Xin Huang; Li Qiu; Yan Li
Journal:  Neurol Sci       Date:  2015-05-08       Impact factor: 3.307

7.  Positive selection on MHC class II DRB and DQB genes in the bank vole (Myodes glareolus).

Authors:  Kristin Scherman; Lars Råberg; Helena Westerdahl
Journal:  J Mol Evol       Date:  2014-04-20       Impact factor: 2.395

8.  Influence of HLA-DRB1 and HLA-DQB1 alleles on IgG antibody response to the P. vivax MSP-1, MSP-3α and MSP-9 in individuals from Brazilian endemic area.

Authors:  Josué C Lima-Junior; Rodrigo N Rodrigues-da-Silva; Dalma M Banic; Jianlin Jiang; Balwan Singh; Gustavo M Fabrício-Silva; Luís C S Porto; Esmeralda V S Meyer; Alberto Moreno; Maurício M Rodrigues; John W Barnwell; Mary R Galinski; Joseli de Oliveira-Ferreira
Journal:  PLoS One       Date:  2012-05-23       Impact factor: 3.240

9.  A splice acceptor variant in HLA-DRA affects the conformation and cellular localization of the class II DR alpha-chain.

Authors:  Alessandro Didonna; Vincent Damotte; Hengameh Shams; Atsuko Matsunaga; Stacy J Caillier; Ravi Dandekar; Maneesh K Misra; Mohammad R K Mofrad; Jorge R Oksenberg; Jill A Hollenbach
Journal:  Immunology       Date:  2020-10-19       Impact factor: 7.397

10.  Inhibition of acid ceramidase regulates MHC class II antigen presentation and suppression of autoimmune arthritis.

Authors:  Dan Zhao; Laela M Hajiaghamohseni; Xiang Liu; Zdzislaw M Szulc; Aiping Bai; Alicja Bielawska; James S Norris; Sakamuri V Reddy; Yusuf A Hannun; Azizul Haque
Journal:  Cytokine       Date:  2020-07-29       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.